Expected Recognition of an Extraordinary Gain from the Sale of Investment Securities
AuBEX CORPORATION
2 listed securities held by the Company
To improve the efficiency of held assets and strengthen the company's financial position.
¥46 million (expected, extraordinary gain)
The consolidated accounting period for the third quarter of the fiscal year ending March 2027
The consolidated earnings forecast for the fiscal year ending March 2027 remains unchanged at this time. The company will promptly announce any necessary revision to the earnings forecast.
The securities are expected to be sold by the end of November 2026, and the gain on the sale of investment securities is expected to be recorded as an extraordinary gain in the consolidated third quarter of the fiscal year ending March 2027. The consolidated earnings forecast for the fiscal year ending March 2027 remains unchanged at this time.
The company will promptly announce any necessary revision to the earnings forecast.
| Item | Details |
|---|---|
| Event name | Expected Recognition of an Extraordinary Gain from the Sale of Investment Securities |
| Date of occurrence | 10 November 2026 (the date the Board of Directors resolved to sell the securities) |
| Date recognized / date notice received | 10 November 2026 (resolved at the Board of Directors meeting held today) |
| Subject Entity | AuBEX CORPORATION |
| Target Locations / Products | 2 listed securities held by the Company |
| Cause | To improve the efficiency of held assets and strengthen the company's financial position. |
| Amount of Impact on Business Performance | ¥46 million (expected, extraordinary gain) |
| Accounting period in which recognized | The consolidated accounting period for the third quarter of the fiscal year ending March 2027 |
| Impact on Earnings Forecast | The consolidated earnings forecast for the fiscal year ending March 2027 remains unchanged at this time. The company will promptly announce any necessary revision to the earnings forecast. |
| Outlook | The securities are expected to be sold by the end of November 2026, and the gain on the sale of investment securities is expected to be recorded as an extraordinary gain in the consolidated third quarter of the fiscal year ending March 2027. The consolidated earnings forecast for the fiscal year ending March 2027 remains unchanged at this time. |
| Planned follow-up disclosure | The company will promptly announce any necessary revision to the earnings forecast. |
Items this document does not state (14)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To improve the efficiency of held assets and strengthen the company's financial position.